{"success":true,"data":{"pressRelease":{"id":"116158","rtpr_id":"nPnbRHz10a","ticker":"BYAH","exchange":"NASDAQ","all_tickers":["BYAH"],"title":"PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit","author":"PR Newswire","published_at":"2026-08-11T23:47:00.026Z","article_body":"PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit\n\nPR Newswire\n\nNEW YORK, Aug. 11, 2026\n\nNEW YORK, Aug. 11, 2026 /PRNewswire/ --\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of\nsecurities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH)\nbetween December 27, 2024 and July 8, 2025, inclusive (the \"Class Period\"), of\nthe important September 28, 2026 lead plaintiff deadline.\n\nSo what: If you purchased Park Ha securities during the Class Period you may\nbe entitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWhat to do next: To join the Park Ha class action, go to\nhttps://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=1970397821&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than September 28,\n2026. A lead plaintiff is a representative party acting on behalf of other\nclass members in directing the litigation.\n\nWhy Rosen Law: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer\nrecognition. Many of these firms do not actually handle securities class\nactions, but are merely middlemen that refer clients or partner with law firms\nthat actually litigate the cases. Be wise in selecting counsel. The Rosen Law\nFirm represents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved the largest ever securities class action settlement against a\nChinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class\nAction Services for number of securities class action settlements in 2017. The\nfirm has been ranked in the top 4 each year since 2013 and has recovered\nbillions of dollars for investors. In 2019 alone the firm secured over $438\nmillion for investors. In 2020, founding partner Laurence Rosen was named by\nlaw360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been\nrecognized by Lawdragon and Super Lawyers.\n\nDetails of the case: According to the lawsuit, throughout the Class Period,\nDefendants made materially false and/or misleading statements and failed to\ndisclose material adverse facts about Park Ha Biological Technology Co. Ltd.'s\nbusiness, operations, and the true nature of its securities trading activity.\nSpecifically, defendants failed to disclose that: (1) Park Ha was the subject\nof a fraudulent stock promotion scheme involving social media-based\nmisinformation and impersonated financial professionals; (2) Park Ha's public\nstatements and risk disclosures omitted any mention of the false rumors and\nartificial trading activity driving the stock price; (3) Park Ha's IPO was\nintentionally structured with an extremely low public float to enable the\nmanipulation scheme; and (4) as a result of the foregoing, defendants'\npositive statements about Park Ha's business, operations, and prospects were\nmisleading and/or lacked a reasonable basis.\n\nTo join the Park Ha class action, go to\nhttps://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=1970397821&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=898621387&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm)\n, on Twitter: https://twitter.com/rosen_firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=267097503&u=https%3A%2F%2Ftwitter.com%2Frosen_firm&a=https%3A%2F%2Ftwitter.com%2Frosen_firm)\n or on Facebook: https://www.facebook.com/rosenlawfirm/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=4292254898&u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F)\n.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\n\n     Laurence Rosen, Esq.\n     Phillip Kim, Esq.\n     The Rosen Law Firm, P.A.\n     275 Madison Avenue, 40th Floor\n     New York, NY 10016\n     Tel: (212) 686-1060\n     Toll Free: (866) 767-3653\n     Fax: (212) 202-3827\n     case@rosenlegal.com (mailto:case@rosenlegal.com)\n     www.rosenlegal.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=1645212243&u=http%3A%2F%2Fwww.rosenlegal.com%2F&a=www.rosenlegal.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302848972.html\n(https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302848972.html)\n\nSOURCE THE ROSEN LAW FIRM, P. A.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2860531\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnbRHz10a","title":"PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit","author":"PR Newswire","ticker":"BYAH","created":"2026-08-11T23:47:00.026Z","tickers":["BYAH"],"exchange":"NASDAQ","article_body":"PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit\n\nPR Newswire\n\nNEW YORK, Aug. 11, 2026\n\nNEW YORK, Aug. 11, 2026 /PRNewswire/ --\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of\nsecurities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH)\nbetween December 27, 2024 and July 8, 2025, inclusive (the \"Class Period\"), of\nthe important September 28, 2026 lead plaintiff deadline.\n\nSo what: If you purchased Park Ha securities during the Class Period you may\nbe entitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWhat to do next: To join the Park Ha class action, go to\nhttps://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=1970397821&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than September 28,\n2026. A lead plaintiff is a representative party acting on behalf of other\nclass members in directing the litigation.\n\nWhy Rosen Law: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer\nrecognition. Many of these firms do not actually handle securities class\nactions, but are merely middlemen that refer clients or partner with law firms\nthat actually litigate the cases. Be wise in selecting counsel. The Rosen Law\nFirm represents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved the largest ever securities class action settlement against a\nChinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class\nAction Services for number of securities class action settlements in 2017. The\nfirm has been ranked in the top 4 each year since 2013 and has recovered\nbillions of dollars for investors. In 2019 alone the firm secured over $438\nmillion for investors. In 2020, founding partner Laurence Rosen was named by\nlaw360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been\nrecognized by Lawdragon and Super Lawyers.\n\nDetails of the case: According to the lawsuit, throughout the Class Period,\nDefendants made materially false and/or misleading statements and failed to\ndisclose material adverse facts about Park Ha Biological Technology Co. Ltd.'s\nbusiness, operations, and the true nature of its securities trading activity.\nSpecifically, defendants failed to disclose that: (1) Park Ha was the subject\nof a fraudulent stock promotion scheme involving social media-based\nmisinformation and impersonated financial professionals; (2) Park Ha's public\nstatements and risk disclosures omitted any mention of the false rumors and\nartificial trading activity driving the stock price; (3) Park Ha's IPO was\nintentionally structured with an extremely low public float to enable the\nmanipulation scheme; and (4) as a result of the foregoing, defendants'\npositive statements about Park Ha's business, operations, and prospects were\nmisleading and/or lacked a reasonable basis.\n\nTo join the Park Ha class action, go to\nhttps://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=1970397821&u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin)\n or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com)  for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=898621387&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm)\n, on Twitter: https://twitter.com/rosen_firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=267097503&u=https%3A%2F%2Ftwitter.com%2Frosen_firm&a=https%3A%2F%2Ftwitter.com%2Frosen_firm)\n or on Facebook: https://www.facebook.com/rosenlawfirm/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=4292254898&u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F)\n.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\n\n     Laurence Rosen, Esq.\n     Phillip Kim, Esq.\n     The Rosen Law Firm, P.A.\n     275 Madison Avenue, 40th Floor\n     New York, NY 10016\n     Tel: (212) 686-1060\n     Toll Free: (866) 767-3653\n     Fax: (212) 202-3827\n     case@rosenlegal.com (mailto:case@rosenlegal.com)\n     www.rosenlegal.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4750694-1&h=1645212243&u=http%3A%2F%2Fwww.rosenlegal.com%2F&a=www.rosenlegal.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302848972.html\n(https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302848972.html)\n\nSOURCE THE ROSEN LAW FIRM, P. A.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2860531\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-11T23:47:00.093927073Z","server_sent_at_ms":1786492020093},"received_at":"2026-08-11T23:47:00.146Z","source_url":"https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302848972.html"},"analysis":{"id":"105148","press_release_id":"116158","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Rosen Law Firm issued a solicitation notice for purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) securities regarding a class action lawsuit.\n\nThe lawsuit alleges the company made false statements about a fraudulent stock promotion scheme and the nature of its IPO structure.\n\nInvestors who purchased securities between December 27, 2024 and July 8, 2025 have until September 28, 2026 to seek lead plaintiff status.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.","namedEntities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Attorney"}],"products":[],"companies":[{"name":"The Rosen Law Firm, P.A.","relationship":"plaintiff law firm"},{"name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Rosen Law Firm. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[{"ticker":"PHH","relevance":"same_issuer"}],"primary":"BYAH"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Rosen Law Firm issued a solicitation notice for purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) securities regarding a class action lawsuit.\n\nThe lawsuit alleges the company made false statements about a fraudulent stock promotion scheme and the nature of its IPO structure.\n\nInvestors who purchased securities between December 27, 2024 and July 8, 2025 have until September 28, 2026 to seek lead plaintiff status.","key_figures":{},"named_entities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Attorney"}],"products":[],"companies":[{"name":"The Rosen Law Firm, P.A.","relationship":"plaintiff law firm"},{"name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-12T01:41:17.628Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":76242,"modelName":"glm-4.7"}}